Catalysts for Teva Pharmaceuticals USA Inc
453 tracked
Feb 8, 2023
approval
FENTANYL CITRATE โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Jan 19, 2023
approval
NIZORAL ANTI-DANDRUFF (KETOCONAZOLE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Dec 16, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Dec 8, 2022
approval
FENTORA (FENTANYL CITRATE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Dec 8, 2022
approval
ACTIQ (FENTANYL CITRATE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Nov 22, 2022
approval
FENTORA (FENTANYL CITRATE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Nov 22, 2022
approval
ACTIQ (FENTANYL CITRATE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Oct 27, 2022
approval
VIGABATRIN โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Oct 27, 2022
approval
VIGABATRIN โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Oct 12, 2022
approval
VIGABATRIN โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Oct 12, 2022
approval
VIGABATRIN โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Oct 6, 2022
approval
CLARAVIS (ISOTRETINOIN) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Oct 6, 2022
approval
CLARAVIS (ISOTRETINOIN) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Aug 23, 2022
approval
CLARAVIS (ISOTRETINOIN) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Aug 23, 2022
approval
CLARAVIS (ISOTRETINOIN) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Aug 17, 2022
approval
FENTORA (FENTANYL CITRATE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Aug 17, 2022
approval
ACTIQ (FENTANYL CITRATE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Jun 17, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Jun 17, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Jun 13, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Jun 7, 2022
approval
FINASTERIDE โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Jun 7, 2022
approval
FINASTERIDE โ FDA approval
Teva Pharmaceuticals USA Inc
โ
May 13, 2022
approval
NIZORAL ANTI-DANDRUFF (KETOCONAZOLE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
May 4, 2022
approval
POMALIDOMIDE โ FDA approval
Teva Pharmaceuticals USA Inc
โ
May 3, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Mar 31, 2022
approval
OXALIPLATIN โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Dec 15, 2021
approval
MORPHINE SULFATE โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Dec 15, 2021
approval
MORPHINE SULFATE โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Dec 15, 2021
approval
MORPHINE SULFATE โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Dec 3, 2021
approval
FENTORA (FENTANYL CITRATE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ